0
Views
22
CrossRef citations to date
0
Altmetric
Transcriptional Regulation

κB Site-Dependent Activation of the Interleukin-2 Receptor α-Chain Gene Promoter by Human c-Rel

, , , , , & show all
Pages 4067-4075 | Received 21 Apr 1992, Accepted 11 Jun 1992, Published online: 01 Apr 2023
 

Abstract

The cis-acting control elements of the interleukin-2 receptor α-chain (IL-2Rot) gene contain a potent κB-like enhancer whose activity can be induced by various mitogenic stimuli. Recent cloning of the p50 and p65 subunits of the κB-binding protein NF-κB complex revealed a striking sequence homology of these proteins with the c-rel proto-oncogene product (c-Rel). On the basis of this homology, we examined the potential role of c-Rel in controlling IL-2Rα transcription. We now demonstrate that the recombinant human c-Rel protein binds to the κB element in the IL-2Rα promoter and results in alteration of the DNA structure in the adjacent downstream regulatory elements containing the CArG box and the GC box. We found that human c-Rel can activate transcription from the IL-2Rα promoter, but not the κB-containing human immunodeficiency virus type 1 promoter, upon cotransfection into Jurkat T cells. Furthermore, truncation of the carboxyl terminus of c-Rel results in a c-Rel mutant (RelNA) that (i) localizes exclusively in the nucleus and (ii) acts in synergy with wild-type c-Rel in activating transcription from the κB site of the IL-2Rα promoter. Finally, induction of surface IL-2Rα expression coincides with the induced levels of endogenous c-Rel and induced c-Rel binding to the IL-2Rα κB site. Our study identified c-Rel as one component of the Rel/NF-κB-family proteins involved in the κB-dependent activation of IL-2Rα gene expression. Furthermore, our results suggest that a RelNA-like cellular factor (e.g·, NF-κB p50 or p49 subunit) acts in synergy with c-Rel during T-cell activation. * †

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.